导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.65% | 572/1050 |
| 近一周 | -2.42% | 598/1104 |
| 近一月 | -7.57% | 878/1102 |
| 近一季 | -12.55% | 767/1092 |
| 近半年 | -4.71% | 591/1070 |
| 近一年 | -7.41% | 702/1018 |
| 近两年 | 40.28% | 583/926 |
| 近三年 | 4.81% | 626/834 |
| 成立以来 | 1.56% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.32% 672/1070 |
20.22% 385/1101 |
- - |
- - |
| 2025 | 14.94% 753/1065 |
9.12% 179/1014 |
-1.72% 824/1038 |
20.33% 601/1050 |
-10.94% 913/1065 |
| 2024 | -4.65% 695/1011 |
-8.56% 723/960 |
-6.24% 704/983 |
10.76% 570/991 |
0.41% 295/1011 |
| 2023 | -12.11% 401/952 |
0.87% 585/880 |
-3.99% 446/895 |
-6.35% 382/915 |
-3.10% 333/952 |
| 2022 | -23.87% 462/867 |
-21.38% 596/773 |
11.72% 199/806 |
-14.28% 526/845 |
1.11% 376/867 |
| 2021 | 11.17% 229/740 |
-5.77% 374/580 |
10.33% 347/659 |
-2.79% 283/704 |
10.00% 84/740 |
| 2020 | - - |
- - |
- - |
- - |
19.19% 132/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 朱雀企业优选C VS. 东吴新产业精选股票A(580008) |